Home / Hydroxychloroquine / United States
US ATC P01BA02 · updated 2 Nov 2026
Hydroxychloroquine shortage in United States
Is there a Hydroxychloroquine shortage in United States?
Yes. As of 2 Nov 2026, 1 Hydroxychloroquine product is reported short in United States, the first since 5 Jan 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Spain. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Hydroxychloroquine Sulfate, Tablet, 200 mg (NDC 0093-2401-01) discontinuation | Teva Pharmaceuticals USA, Inc. | 5 Jan 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).